TGFBR2 Knockout HEK293 Cell Line

TGFBR2 Knockout HEK293 Cell Line
Cat.No.:

EDC07591

Species:

Human

Cell Name:

HEK293

Gene:

TGFBR2

Gene ID:

7048

Size:

1×10⁶cells

TGFBR2 Knockout Cell Line (HEK293) is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performance Cas9 Protein and Hassle-Free Cell Selection.
Cat.No. EDC07591
Product Name TGFBR2 Knockout Cell Line (HEK 293)
Cell Line HEK293
Cellosaurus ID CVCL_0045
Cell Line Synonyms Hek293, HEK-293, HEK/293, (HEK)293, HEK 293, HEK,293, 293, 293 HEK, 293 Ad5, Graham 293, Graham-293, Human Embryonic Kidney 293
Gene TGFBR2
NCBI Gene ID
Gene Synonyms AAT3|FAA3|LDS1B|LDS2|LDS2B|MFS2|RIIC|TAAD2|TBR-ii|TBRII|TGFR-2|TGFbeta-RII|tbetaR-II
Summary
The protein encoded by this gene is a transmembrane protein that has a protein kinase domain, forms a heterodimeric complex with TGF-beta receptor type-1, and binds TGF-beta. This receptor/ligand complex phosphorylates proteins, which then enter the nucleus and regulate the transcription of genes related to cell proliferation, cell cycle arrest, wound healing, immunosuppression, and tumorigenesis. Mutations in this gene have been associated with Marfan Syndrome, Loeys-Deitz Aortic Aneurysm Syndrome, and the development of various types of tumors. Alternatively spliced transcript variants encoding different isoforms have been characterized. [provided by RefSeq, Aug 2017]
Associated Diseases Non-tumor
Morphology Adherent
Passage Ratio 1/5,2days
Complete Culture Medium DMEM + 10% FBS
Freezing Medium 95% Complete culture medium+ 5% DMSO
QC Indels validated by Sanger sequencing; sterility confirmed via microbial testing.
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
LociSTR Info (Sample Cell)
Sample Cell Line: HEK293
STR Info (Cell bank)
Cell Line: HEK293
Allele1Allele2Allele1Allele2
Amelogenin X X
CSF1P0 12 11 12
D2S1338 19 19
D3S1358 15 17 15 17
D5S818 8 8 9
D7S820 11 12 11 12
D8S1179 12 14 12 14
D13S317 12 14 12 14
D16S539 9 13 9 13
D18S51 17 18 17 18
D19S433 15 18 15 18
D21S11 28 30.2 28 30.2
FGA 23 23
Penta D 9 10 9 10
Penta E 7 15 7 15
TH01 7 9.3 7 9.3
TPOX 11 11
vWA 16 19 16 19
D6S1043 11 11
D12S391 19 21 11 15
D2S441 11 15 11 15
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.

FAQ

The choice depends on whether you are studying TGF-β signaling cascade biology or modeling TGFBR2 loss-of-function in disease contexts (Loeys-Dietz syndrome, microsatellite-instable cancers). The Knockout line is the standard tool for asking whether TGFBR2 is required for SMAD2/3 phosphorylation and downstream TGF-β responses. Overexpression is useful for studying disease-associated TGFBR2 missense mutations or constitutively active variants. For TGF-β pathway research, the EDITGENE TGFBR2 Knockout in HEK293 is a mechanistic platform — HEK293 has a long history in TGF-β signaling research, supporting SMAD reporter assays and rescue with structural variants. Rescue with wild-type, kinase-dead, or disease-mutant TGFBR2 enables structure-function studies and disease modeling.
Primary applications: • SMAD signaling: phospho-SMAD2/3 Western blot and SMAD-responsive reporter (CAGA-luc) assays to assess TGFBR2-dependent canonical TGF-β signaling. • TGF-β responsive gene expression: analysis of canonical TGF-β target genes (PAI-1, SMAD7, p15/CDKN2B) following TGF-β stimulation. • Disease mutation rescue: introduction of Loeys-Dietz syndrome-associated TGFBR2 mutations or MSI-associated truncating mutations for genotype-function studies. • Non-canonical TGF-β signaling: TAK1, MAPK, and PI3K activation analysis to assess TGFBR2-dependent non-SMAD pathways. EDITGENE recommends this model for researchers investigating TGF-β signaling biology, Loeys-Dietz syndrome, and TGFBR2-related cancer biology.
Yes. TGFBR2 rescue experiments are well-established in TGF-β pathway research: • Construct design: use a codon-modified TGFBR2 sequence with a cytoplasmic C-terminal tag (FLAG, HA). TGFBR2 is a type I membrane serine/threonine kinase — extracellular ligand-binding domain and intracellular kinase domain must both be preserved. • Kinase-dead rescue: the K277R mutation in the active site lysine abolishes kinase activity and is the standard control for distinguishing kinase from receptor-binding functions. • Disease mutation rescue: Loeys-Dietz syndrome-associated TGFBR2 mutations or MSI-associated frameshift mutations enable genotype-function studies. • Functional readout: rescue should restore TGF-β-induced SMAD2/3 phosphorylation (Western blot) and CAGA-luc reporter activity. HEK293 transduces efficiently with lentivirus and has established protocols for TGF-β pathway rescue experiments.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.

Required Accessories

Related Products

Flash CRISPR Knockout Kit(Universal Version)Flash CRISPR Knockout Kit(Universal Version)
Flash-Pro CRISPR KO Kit (For Organoids / Stem Cells)Flash-Pro CRISPR KO Kit (For Organoids / Stem Cells)
TGFBR2 Knockout A-549 Cell LineTGFBR2 Knockout A-549 Cell Line
TGFBR2 Knockout HCT 116 Cell LineTGFBR2 Knockout HCT 116 Cell Line
TGFBR2 Knockout HeLa Cell LineTGFBR2 Knockout HeLa Cell Line

Related Services

Knockout Cell LineKnockout Cell Line
Contact Us
*
*
*
*
How did you hear about us: